Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

CNBC Published Updated Stocks
Sign in to save

Why it matters

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence.

Expected market reaction

Neutral Confidence 94% How confidence is read Horizon: Short term Impact: Low

Evidence trail

Evidence
Source CNBC
Claim Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says
AI inference Neutral · 94%
Generated 2026-03-18 18:06

AI provenance

Analysed by FinBERT Methodology v1.0 Generated
Technical identifiers
Provider tag
huggingface-ProsusAI/finbert
Analysis version
huggingface-ProsusAI/finbert
Article id
59756

Original source

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

Read the full article on CNBC

Original article published by CNBC on March 18, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage

This model on similar stories

FinBERT · 85.4% correct across 123 scored calls on equities See the full record